Morgan Stanley Upgrades Lineage to Overweight, Maintains Price Target to $47

Benzinga Newsdesk www.benzinga.com Positive 80.7%

Neg 0% Neu 0% Pos 80.7%

Morgan Stanley analyst Ronald Kamdem upgrades Lineage (NASDAQ:LINE) from Equal-Weight to Overweight and maintains the price target from $47 to $47.